5804. Inhepat tablets.    (F.D.C. No. 42276.   S. Nos. 31-869/70 P.)
QUANTITY:   400   100-tablet btls., 6   500-tablet btls., and 2 drums, each con-
taining about 47,422 tablets, at New York, N.Y., in possession of Brown Drug
Co.
SHIPPED: The tablets in the drums were shipped on 7-23-58 and 7-31-58,
from Fort Erie, Canada, and the tablets in the bottles were shipped in bulk
on 8-12-57 and 8-30-57, from Montreal, Canada.
LABEL IN PART: (Btl.) "INHEPAT Each e.c. tablet contains: Pancreatin
100 mg. Pancrein 50 mg. Sodium Glycocholate 30 mg. Sodium Taurocholate
30 mg. Sodium Dehydrocholate 20 mg. Hepatin* 50 mg. Caseara Sagrada
10 mg. Vitamin Bi 0.1 mg. Riboflavin 0.1 mg. *Liver Extract 1:5,"
(drum) "Special Formula Pancrepatine Pills * * * Each sugar coated pill
contains: Pancreatin 100 mg. Desiccated whole pancreas 50 mg. Sodium
glycocholate 30 mg. Sodium taurocholate 30 mg. Sodium dehydrocholate
20 mg. Hepatin* 50 mg. Antipyrine 25 mg. Caseara Sagrada 10 mg.
Vitamin Bi 0.1 mg.   Riboflavin 0.1 mg.   *Liver extract 1: 5."
ACCOMPANYING LABELING: Cards designated "5 Points to Observe in Inhepat"
and leaflets designated "Treating the Diabetic "Without the Needle" and "In
Diabetes Mellitus."
RESULTS OF INVESTIGATION : The tablets in the bottles were repackaged from
the above-mentioned bulk shipment from Montreal, Canada, and labeled by
the Brown Drug Co.
The above-mentioned accompanying labeling was printed at New York, N.T.,
from formats furnished by the Anglo-French Drug Company, Ltd., of Montreal,
Canada.
LIBELED:   11-13-58, S. Dist. N.T.
CHARGE: 502(a)-the labeling accompanying the articles, while held for sale,
contained false and misleading representations that the articles were an ade-
quate and effective treatment for diabetes mellitus.
DISPOSITION :   12-24-58.   Consent-claimed by Brown Drug Co. and relabeled.